1Sheron N, Lau J Y N, Hofman J, et al. Dose dependent increase in plasma interleukin -6 after recombinant tumor necrosis factor infusion in humans. Clin Exp Immunol. 1999, 82:427.
2何浩明.[A]..医学实践研究论文集[C].北京:原子能出版社,1997.126.
3Ni WAT, Niva ZZKI, T, Sotom B, et al. Interleukin -8 and biocompatibility of dialysis membranee. Am J Nephral. 1995, 15:181.
4Kanazawa H, Kurihara N, Otsuka T, et al. Clinical significance of serum concentration of interleukin 8 in patients with bronchial asthma or chronic pulmonary emphysema[J]. Respiration, 1996,63(4):236-402.
5Shawnd. Aaron, JonathanB, Angel, Mary Lunau, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease[J]. Am. J.Respir. Crit. Care Med., 2001,163(2):349-355.
6W.l. De Boer, Cytokines and therapy in COPD a promising combination[R]. Chest, 2002,121(5):209S-218.
7lsabelle P, Peter GG, Roxanne K, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma[J]. Thorax,1992,47(1):25-29.
8Smith WB, Gamble JR, Clark Lewisi, et al. Interleukin-8 induces neutrophil transendothelial migration[J]. Immunology, 1991,72(1):65.
9Keatings VM. Differences in interleuking-8 and tumor necrosis factoralpha in induced Sputum from patients with chronic obstructive pulmonary disease or asthma[J]. Am. J. Respir. Crit.Care Med., 1996,153(2):530-534.
10Martin J. Tobin. Chronic obstructive pulmonary disease, pollution,pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2002[R]. Am. J. Respir. Crit. Care Med.,2003,167(3) :356-370.
